Quick Answer
Theriva Biologics, Inc. reported Net Income of -$18.35 million for fiscal year 2023.
Theriva Biologics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2023 | -$18.35M | +6.8% |
| 2022 | -$19.68M | -38.0% |
| 2021 | -$14.27M | -42.1% |
| 2020 | -$10.04M | +34.4% |
| 2019 | -$15.30M | -14.5% |
| 2018 | -$13.37M | +11.9% |
| 2017 | -$15.17M | +44.3% |
| 2016 | -$27.25M | +37.7% |
| 2015 | -$43.74M | -121.1% |
| 2014 | -$19.78M | -60.6% |
| 2013 | -$12.32M | +27.8% |
| 2012 | -$17.07M | -109.4% |
| 2011 | -$8.15M | -376.3% |
| 2010 | -$1.71M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | -$3.30M | +26.4% | +26.4% |
| September 30, 2022 | -$4.49M | -37.2% | +9.6% |
| June 30, 2022 | -$4.97M | -55.5% | -16.3% |
| March 31, 2022 | -$4.27M | -68.5% | -30.6% |
| September 30, 2021 | -$3.27M | -55.6% | -2.4% |
| June 30, 2021 | -$3.19M | -11.4% | -26.0% |
| March 31, 2021 | -$2.54M | +14.4% | -20.6% |
| September 30, 2020 | -$2.10M | +58.9% | +26.6% |
- Theriva Biologics, Inc. showed an increase of +6.8% in Net Income compared to the prior fiscal year.
- Over the 2010–2023 period, Theriva Biologics, Inc.’s net income has declined by 972.4% (from -$1.71 million to -$18.35 million).
- The most recent figure is from Theriva Biologics, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 25, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: